144 related articles for article (PubMed ID: 37805479)
1. The clinical utility of circulating cell division control 42 in small-vessel coronary artery disease patients undergoing drug-coated balloon treatment.
Wu L; Li H; Chen H; Fan C; Lu Y; Wei R; Yang G; Jia Y
BMC Cardiovasc Disord; 2023 Oct; 23(1):496. PubMed ID: 37805479
[TBL] [Abstract][Full Text] [Related]
2. Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease.
Shin ES; Jun EJ; Kim S; Kim B; Kim TH; Sohn CB; Her AY; Park Y; Cho JR; Jeong YH; Choi BJ
JACC Cardiovasc Interv; 2023 Feb; 16(3):292-299. PubMed ID: 36609038
[TBL] [Abstract][Full Text] [Related]
3. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease.
Her AY; Shin ES; Kim S; Kim B; Kim TH; Sohn CB; Choi BJ; Park Y; Cho JR; Jeong YH
Cardiovasc Diabetol; 2023 May; 22(1):120. PubMed ID: 37210516
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.
Sim HW; Ananthakrishna R; Chan SP; Low AF; Lee CH; Chan MY; Tay EL; Loh PH; Chan KH; Tan HC; Loh JP
J Invasive Cardiol; 2018 Jul; 30(7):256-261. PubMed ID: 29656281
[TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
Mitsui K; Lee T; Miyazaki R; Hara N; Nagamine S; Nakamura T; Terui M; Okata S; Nagase M; Nitta G; Watanabe K; Kaneko M; Nagata Y; Nozato T; Ashikaga T
Catheter Cardiovasc Interv; 2023 Jul; 102(1):11-17. PubMed ID: 37210618
[TBL] [Abstract][Full Text] [Related]
6. The ability and optimal cutoff value of serum cell division cycle 42 in estimating major adverse cardiac event in STEMI patients treated with percutaneous coronary intervention.
Luan S; Zhang L; Cheng X; Wang Y; Feng Q; Wei L; Jiang F; Liu J
Heart Vessels; 2024 Apr; 39(4):277-287. PubMed ID: 38153423
[TBL] [Abstract][Full Text] [Related]
7. Impact of Optimal Preparation Before Drug-Coated Balloon Dilatation for De Novo Lesion in Patients With Coronary Artery Disease.
Konishi H; Habara M; Nasu K; Koshida R; Kinoshita Y; Tsuchikane E; Terashima M; Matsubara T; Suzuki T
Cardiovasc Revasc Med; 2022 Feb; 35():91-95. PubMed ID: 33766488
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
9. A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.
Giannini F; Latib A; Ancona MB; Costopoulos C; Ruparelia N; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
Catheter Cardiovasc Interv; 2017 Sep; 90(3):380-386. PubMed ID: 28109036
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis.
Nguyen VPT; Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315
[TBL] [Abstract][Full Text] [Related]
11. Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
Sanz Sánchez J; Chiarito M; Cortese B; Moretti A; Pagnotta P; Reimers B; Stefanini GG; Ferrante G
Catheter Cardiovasc Interv; 2021 Jul; 98(1):66-75. PubMed ID: 32592437
[TBL] [Abstract][Full Text] [Related]
12. A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions.
Kook H; Joo HJ; Park JH; Hong SJ; Yu CW; Lim DS
BMC Cardiovasc Disord; 2020 Feb; 20(1):83. PubMed ID: 32070287
[TBL] [Abstract][Full Text] [Related]
13. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
14. Angiography and Optical Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTIAL for the Treatment of In-Stent Restenosis.
de la Torre Hernández JM; Garcia Camarero T; Lozano Ruiz-Poveda F; Urbano-Carrillo CA; Sánchez Pérez I; Cano-García M; Saez R; Andrés Morist A; Molina E; Pinar E; Torres A; Lezcano EJ; Gutierrez H; Arnold RJ; Zueco J
Cardiovasc Revasc Med; 2020 Apr; 21(4):508-513. PubMed ID: 31401071
[TBL] [Abstract][Full Text] [Related]
15. Serum histone deacetylase 4 longitudinal change for estimating major adverse cardiovascular events in acute coronary syndrome patients receiving percutaneous coronary intervention.
Xu H; Zhang J; Jia H; Xing F; Cong H
Ir J Med Sci; 2023 Dec; 192(6):2689-2696. PubMed ID: 36849652
[TBL] [Abstract][Full Text] [Related]
16. Clinical research of drug-coated balloon after rotational atherectomy for severe coronary artery calcification.
Dong H; Shan Y; Gong S; Li R; Li Y; Lu X; Sun G
BMC Cardiovasc Disord; 2023 Jan; 23(1):40. PubMed ID: 36681814
[TBL] [Abstract][Full Text] [Related]
17. Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial.
Fahrni G; Scheller B; Coslovsky M; Gilgen N; Farah A; Ohlow MA; Mangner N; Weilenmann D; Wöhrle J; Cuculi F; Leibundgut G; Möbius-Winkler S; Zweiker R; Twerenbold R; Kaiser C; Jeger R;
Clin Res Cardiol; 2020 Sep; 109(9):1114-1124. PubMed ID: 31993736
[TBL] [Abstract][Full Text] [Related]
18. Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial.
Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Leibundgut G; Weilenmann D; Wöhrle J; Richter S; Schreiber M; Mahfoud F; Linke A; Stephan FP; Mueller C; Rickenbacher P; Coslovsky M; Gilgen N; Osswald S; Kaiser C; Scheller B;
Lancet; 2018 Sep; 392(10150):849-856. PubMed ID: 30170854
[TBL] [Abstract][Full Text] [Related]
19. Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease.
Megaly M; Buda K; Saad M; Tawadros M; Elbadawi A; Basir M; Abbott JD; Rinfret S; Alaswad K; Brilakis ES
Cardiovasc Revasc Med; 2022 Feb; 35():76-82. PubMed ID: 33858783
[TBL] [Abstract][Full Text] [Related]
20. A HYbrid APproach Evaluating a DRug-Coated Balloon in Combination With a New-Generation Drug-Eluting Stent in the Treatment of De Novo Diffuse Coronary Artery Disease: The HYPER Pilot Study.
Ielasi A; Buono A; Pellicano M; Tedeschi D; Loffi M; Donahue M; Regazzoli D; De Angelis G; Danzi G; Reimers B; Tespili M
Cardiovasc Revasc Med; 2021 Jul; 28():14-19. PubMed ID: 32933874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
